- The Possibility of Epidermal Growth Factor Receptor Inhibition in Anal Cancer2015 | First Faculty of Medicine
- Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma2018 | Faculty of Medicine in Hradec Králové
- Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions2013 | First Faculty of Medicine
- Cannabinoid Receptor 1 Inhibition Causes Seizures During Anesthesia Induction in Experimental Sepsis2012 | Faculty of Medicine in Hradec Králové
- Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study2016 | First Faculty of Medicine
- Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration2018 | First Faculty of Medicine
- Tapentadol - a novel opioid analgesic inhibiting noradrenaline reuptake2012 | Third Faculty of Medicine
- New dual small molecules for Alzheimer's disease therapy combining histamine H-3 receptor (H3R) antagonism and calcium channels blockade with additional Cholinesterase inhibition2019 | Publication without faculty affiliation
- Structure, Function, and Pharmacology of NMDA Receptor Channels2014 | Central Library of Charles University
- Biological variation of proprotein convertase subtilisin/kexin type 9 (PCSK9) in human serum2021 | First Faculty of Medicine, Third Faculty of Medicine
- In vitro functional interactions of acetylcholine esterase inhibitors and muscarinic receptor antagonists in the urinary bladder of the rat2014 | Faculty of Pharmacy in Hradec Králové
- Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis2017 | First Faculty of Medicine
- Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis2008 | Third Faculty of Medicine